Eurofins-Cerep Past Earnings Performance

Past criteria checks 2/6

Eurofins-Cerep has been growing earnings at an average annual rate of 25.8%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 13.9% per year. Eurofins-Cerep's return on equity is 11.8%, and it has net margins of 17.3%.

Key information

25.8%

Earnings growth rate

n/a

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate13.9%
Return on equity11.8%
Net Margin17.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Investors Aren't Entirely Convinced By Eurofins-Cerep SA's (EPA:ALECR) Revenues

Oct 18
Investors Aren't Entirely Convinced By Eurofins-Cerep SA's (EPA:ALECR) Revenues

Eurofins-Cerep SA's (EPA:ALECR) Subdued P/S Might Signal An Opportunity

Jun 26
Eurofins-Cerep SA's (EPA:ALECR) Subdued P/S Might Signal An Opportunity

Eurofins-Cerep SA (EPA:ALECR) Screens Well But There Might Be A Catch

Sep 28
Eurofins-Cerep SA (EPA:ALECR) Screens Well But There Might Be A Catch

Revenue & Expenses Breakdown

How Eurofins-Cerep makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALECR Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23448140
31 Dec 224812130
30 Sep 224711130
30 Jun 224611120
31 Mar 224410120
31 Dec 214210120
30 Sep 21399110
30 Jun 21368110
31 Mar 21357110
31 Dec 20336110
30 Sep 20336110
30 Jun 20336100
31 Mar 20325100
31 Dec 19314100
30 Sep 1929490
30 Jun 1927390
31 Mar 1926390
31 Dec 1825490
30 Sep 1825480
30 Jun 1824480
31 Mar 1824480
31 Dec 1724480
30 Sep 1724380
30 Jun 1725380
31 Mar 1724380
31 Dec 1624280
30 Sep 1624380
30 Jun 1624380
31 Mar 1623380
31 Dec 1523280
30 Sep 1521180
30 Jun 1520080
31 Mar 1519080
31 Dec 1419080
30 Sep 1419080
30 Jun 1419080
31 Mar 1419080
31 Dec 1319090

Quality Earnings: ALECR has high quality earnings.

Growing Profit Margin: ALECR's current net profit margins (17.3%) are lower than last year (24.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALECR's earnings have grown significantly by 25.8% per year over the past 5 years.

Accelerating Growth: ALECR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ALECR had negative earnings growth (-33.7%) over the past year, making it difficult to compare to the Life Sciences industry average (-1.4%).


Return on Equity

High ROE: ALECR's Return on Equity (11.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 05:21
End of Day Share Price 2024/12/18 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eurofins-Cerep SA is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guillaume CuvillierGilbert Dupont
Cédric MoreauNatixis S.A.
Rodolphe BesserveSociete Generale Cross Asset Research